JT to Return Rights to Gilead’s 6 HIV Agents in 2019, Get 63.1 Billion Yen

November 30, 2018
Japan Tobacco said on November 29 that it will return exclusive Japanese rights for six HIV agents of Gilead Sciences to the big biotech in 2019 as they wrapped up their talks launched earlier this year to terminate their 15-year-old...read more